Basically, deficiency in cathepsin K in humans and animals reflected a central role of this protease in bone resorption and, thus, have rendered the enzyme as a novel therapeutic target for treating osteoporosis and other disorders that are characterized by an elevation in bone resorption [46]. Here, CTSK is linked to osteoporosis.